ENLT Q1 2026 Earnings Positive EPS Surprise Drives Modest Stock Gain Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline HCTI Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises Slightly PAGS Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Unavailable IMMR Q3 2025 Earnings Strong EPS Beat Drives Positive Market Reaction vTv Therapeutics Q1 2026 Earnings Strong EPS Surprise Driven by NonOperating Items Stock Declines